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Objective: To investigate the significance of circulat-
ing  adhesion  molecules  associated  with  leucocyte-
endothelial cell interactions in asthma, serum levels
of  soluble  E  (sE)-selectin,  soluble  P  (sP)-selectin,
soluble  L  (sL)-selectin,  and  soluble  vascular  cell
adhesion  molecule-1  (sVCAM-1)  were  measured  in
mild, moderate and severe asthma.
Method:  Serum  levels  of  sE-selectin,  sP-selectin,  sL-
selectin, and sVCAM-1 were measured in 32  women
with asthma and 30 healthy donors using an enzyme-
linked  immunosorbent  assay  method.  Twenty
patients were suffering from severe asthma, and 12
from mild/moderate asthma.
Results:  Serum sE-selectin and sVCAM-1 levels from
patients with asthma were significantly higher than
those  observed  in  healthy  donors  (p <  0.01).  The
levels  of  sP-selectin  were  the  same  as  those  of
controls. The level of sE-selectin exhibited an impor-
tant  increase in the  severe asthmatic  patients  com-
pared  with  mild/moderate  asthma  (p <  0.01).  The
sVCAM-1 level was increased in severe asthma when
compared with healthy controls. There was no corre-
lation between the levels of soluble selectins and the
age  of  the  patients.  A  significant  correlation  was
found between sE-selectin and sVCAM-1 levels.
Conclusion: These data indicate that circulating solu-
ble forms of the selectins may have different kinetics
during the clinical course of asthma, suggesting that
they may reflect different inflammatory pathways in
severe asthma. Both sVCAM-1 and sE-selectin may be
useful  immunological  markers  for  monitoring  dis-
ease activity in asthma.
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Introduction
Adherence of leucocytes to endothelial cells (EC) is a
primordial  event  in  the  sequence  of  inflammatory
response. Specific cell adhesion molecules, expressed
on the surface of  leucocytes and/or EC, have been
identified. As  an  initial  event  during  inflammation,
leucocytes  in  the  blood  stream roll  along  EC  with
loose contact, mediated by E-selectin, P-selectin and
L-selectin.1 In the inflammation phase, activation of
leucocyte integrins occurs with expression of immu-
noglobulin-like  adhesion  proteins  on  EC,  including
intercellular  adhesion  molecule-1  and  vascular  cell
adhesion molecule-1 (VCAM-1). The leucocytes that
are  tightly  bound  to  EC  then  migrate  into  the
subendothelial tissue. Soluble forms of these adhesion
molecules  are  released  in  circulation.  Serum  levels
may  be increased in  several inflammatory diseases,
and  particularly  in  asthma. These  circulating  forms
may be biologically active.2
Asthma is  known  as  a  bronchial  chronic  inflam-
matory  disorder.3 Immunological  abnormalities
during  asthma  are  characterized by  marked  activa-
tion  of  the  immune  system,  leading  to  increased
cytokine production by  activated effector cells and
the  induction  of  antigen  expression  on  EC.4 The
factors modulating the activation and recruitment of
circulating  inflammatory  cells  to  the  lung  remain
partially unknown, but an early step in this process
is the interaction of adhesion molecules on circulat-
ing  cells  with  those  on  EC.5 Severe  asthma  is
supposed to involve different pathways as corticos-
teroids  are  much  less  efficient  in  reducing
inflammation.
To investigate the significance of circulating adhe-
sion  molecules  in  the  pathogenesis  of  asthma,  we
measured the serum levels of soluble E (sE)-selectin,
soluble  P  (sP)-selectin,  soluble  L  (sL)-selectin,  and
soluble VCAM-1 (sVCAM-1) in two asthma groups and
compared them with healthy donors.
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Subjects
Patients  were  recruited  from  the  Department  of
Respiratory Diseases (A. Mami Hospital, Ariana, Pavil-
lon  B).  Thirty-two  female  asthma  patients  were
classified  depending  on  severity,  according  to
National  Heart  Lung  and  Blood  Institute  (NHLBI)
criteria.6 All  women  were  non-smokers.  Twenty
women suffered from severe asthma (mean age, 47.6
± 1.3 years; range, 45–56 years), and 12 women had
mild or moderate asthma (mean age, 36.6 ± 2.7 years;
range,  22–38  years).  Patients  with  severe  asthma
were  treated  by  oral  glucosteroids  (10–20mg/day)
and  theophylline.  Patients were  studied  away  from
acute exacerbation. Controls were selected from the
staff of our hospital, and showed no abnormalities on
physical examination and laboratory tests (mean age,
40.2 ± 5.7 years; range, 28–44 years).
Assay methods
Serum levels of sE-selectin, sP-selectin, sL-selectin and
sVCAM-I  were  measured  using  an  enzyme-linked
immunosorbent  assay  kit  (sE-selectin,  British  Bio-
Technology Products Ltd, Abingdon, UK; sL-selectin
and sP-selectin, Bender MedSystems, Vienna, Austria;
sVCAM-I, R&D Systems, Minneapolis, MN, USA).
Statistical analysis
Values are presented as mean  ± standard deviation
(SD). Differences between groups are analyzed using
the Mann-Whitney U-test.
Results
The  female  asthma  patients  enrolled  in  this  study
were  classified  according  to  NHLBI  criteria6 as
suffering  from mild/moderate (group  1)  and severe
asthma (group 2). Values for sE-selectin, sP-selectin,
sL-selectin and SVCAM-1 (Fig. 1A-D) were expressed
as mean ± SD (ng/ml).
The  sE-selectin  levels  (Fig.  1A)  of  the  asthmatic
patients  (98.72  ±  22.5ng/ml,  p <  0.001)  were
significantly  higher  than  those  of  healthy  controls
(42.6  ±  12.7ng/ml).  Patients  with  severe  asthma
exhibited  a  significant  increase  of  sE-selectin  level
(128.53 ± 33.7ng/ml, p < 0.001) compared with all
asthmatic and mild/moderate asthma patients (63.82
± 28.45ng/ml).
Serum  levels  of  sP-selectin  (Fig.  1B)  in  asthma
patients (150.6 ± 15.2ng/ml, p < 0.01) were the same
as healthy controls (168.7 ± 17ng/ml). There was no
difference in the levels of sP-selectin between mild/
moderate asthma (148.78  ± 15.4ng/ml)  and severe
asthma (154.2 ± 16.7ng/ml, p < 0.01).
Serum sL-selectin levels (Fig. 1C) in the group of
asthmatic patients (1589.7 ± 43.5ng/ml) were similar
to controls (1449.5 ± 47.9ng/ml). A weak significant
difference  was  observed  between  mild/moderate
(1492  ±  53.0ng/ml)  and  severe  asthma  (1662.7  ±
39.4ng/ml, p < 0.05)
The sVCAM-1 levels (Fig. 1D) of asthmatic patients
(753 ± 60.8ng/ml) were higher than those of healthy
controls (580 ± 70.7ng/ml; p <0.01). Serum sVCAM-1
levels showed no statistically significant  differences
between  mild/moderate  (761.5  ±  46.2ng/ml)  and
severe asthma (727.3 ± 55.4ng/ml).
Within  the  severe  asthma  group,  there  was  a
significant  correlation  between  sE-selectin  and
sVCAM-1  (r =  0.75,  p <  0.001).  No  significant
correlation was found between serum sL-selectin or
sP-selectin and sVCAM-1 (data not shown). No corre-
lation was found between age and soluble selectins in
our patients.
Discussion
The  selectin  family  consists  of  three  proteins  des-
ignated by the prefixes E (endothelial), P (platelet),
and L (leucocyte). These adhesion molecules are shed
following  proteolytic  cleavage  near  the  transmem-
brane domain or by expression of alternatively spliced
mRNA lacking a transmembrane domain from the cell
surface, following  activation with T helper 2 (Th-2)
cytokines.2 It  has  been  suggested  that  the  soluble
molecules  can  regulate  cell  adhesion  by  down-
regulation as competitive inhibitors, or by upregula-
tion  as  co-signaling  factors.7 More  recently,  soluble
isoforms  have  been  detected  in  the  circulation.
Increased levels of these molecules may reflect the
inflammatory processes of certain diseases.1,2
In the present study, high levels of soluble selectins
and VCAM-1  were found  in  asthmatic women. Our
results  suggest  that  the  activation  of  leucocyte-
endothelial interactions persists  for  mild,  moderate
and  severe  asthma  even  in  the  absence  of  acute
exacerbation. High levels of  soluble selectin during
asthma  reflect  the  upregulation  of  selectin  expres-
sion, and  that the soluble  form  of these molecules
may be useful markers of persistant inflammation.8
An important finding in this work is the significant
correlation found between soluble selectin levels and
severe  asthma.  The  expression  of  E-selectin  is
restricted  to  activated  EC;  increased  levels  of  sE-
selectin in the blood would be taken as conclusive
evidence for the activation of EC1,2 and to represent a
marker  for  endothelial  damage  or  activation  in
asthma.  In  patients  with  allergic  asthma,  E-selectin
and VCAM-1 were overexpressed only on the endothe-
lium.9 It has also been reported that sE-selectin levels
are  increased  in  autoimmune  diseases.10 There  is
evidence that endothelin 1,  a mediator released by
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inflammation and remodeling pathways.11
The higher levels of sE-selectin could be influenced
by  the  estrogen  receptor  that  accumulates  in  the
cytoplasm of smooth muscle cells.12 Soluble selectins
were  found  increased  in  lactating  women.13 Our
asthma  patient  group  was  composed  of  women.
Recent evidence suggest a role for hormonal factors
in  the  etiology  of  asthma.  However,  we  found  no
correlation between soluble selectins and female sex
steroid hormones, neither with estrogen nor proges-
terone (data not shown). In  the same way,  a large
study  reported  no  association  between  hormone
replacement therapy in postmenauposal women and
asthma severity.14
sE-selectin is reported to be only a weak inhibitor of
E-selectin-mediated  adhesion,15 while  it  may  have
cytokine-like functions that activate the polymorpho-
nuclear  cell  CD11b  integrin  receptor,  serving  as  a
chemoattractant.16 Furthermore, Th-1  lymphocytes,
but  not Th-2,  are  able  to  bind  to  E-selectin.17 The
particular increase of this selectin in severe asthma
could suggest an involvement of Th-1 cells in addition
to Th-2 in this group of patients.
P-selectin  is  expressed  on  EC  and  platelets.1
sP-selectin  was  shown  to  prevent  activated  neu-
trophil  adhesion  to  EC  in  vitro.18 In  the  present
report, no differences were  observed in  sP-selectin
levels  between  normal  controls  and  asthmatic
patients.
Soluble selectins in asthma
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FIG. 1. Expression of (A) sE-selectin, (B) sP-selectin, (C) sL-selectin and (D) sVCAM-1 in female asthma patients and in healthy
controls (HC). Patients were selected in the mild/moderate asthma group and the severe asthma group. * Significantly different
when compared with healthy controls (p < 0.01), ** significantly different when compared with all asmathic patients and with
patients with mild/moderate asthma (p <  0.001), and *** significantly different when compared with patients with mild/
moderate asthma (p < 0.05).L-selectin is constitutively expressed on most leuco-
cytes but with varying density.1 The sL-selectin levels
in our asthmatic patients were increased, particularly
in severe asthma. It has been reported that patients
with sepsis or HIV infection have increased levels of
sL-selectin and that these soluble  forms can inhibit
L-selectin-mediated  adhesion  at  physiological
concentrations.19
VCAM-1  is  expressed  on  EC,  epithelia,  macro-
phages, and dendritic cells.15 Soluble forms of VCAM-
1  are  shed  from  cytokine-activated  EC.1 Serum
sVCAM-1 levels in our patients were increased com-
pared with healthy controls, but were similar in mild/
moderate and severe asthmatic patients. Our results
indicate that there is no specific change of sVCAM-1
levels depending on disease severity.
As  several  cytokines  (tumor  necrosis  factor-a,
interleukin-1, interleukin-4) stimulate the expression
of adhesion molecules and allergen exposure induces
the expression of endothelial adhesion molecules in
passively sensitized human bronchus,1,2,20 increased
levels of soluble adhesion molecules were expected to
be found in asthmatics. Leucocyte adhesion mecha-
nisms play an important role in the development of
allergic inflammation in bronchial asthma. Increased
serum  levels  of  sE-selectin  and soluble  intercellular
adhesion  molecule-1  were  observed  during  asthma
exacerbation.21The role of soluble selectins in asthma
is still unknown. The elevated levels of sE-selectin, and
sVCAM-1 appear to correlate with disease severity of
asthma.  It  is  probable  that  these  molecules  play  a
significant role in localization of leucocytes to the site
of  lung  vascular  activation  in  asthma,  as  has  been
shown in other immunologically mediated diseases.1,2
In the presented patients, the increase in soluble
selectins  could  not  be  induced  by  treatment  as
theophylline in vitro inhibited the L-selectin shedding
induced  by  PAF  on  both  eosinophils  and  neu-
trophils.22 In the same way, increases in sE-selectin,
kinins, and albumin after segmental allergen challenge
of  asthmatic  subjects  were  inhibited  by
glucocorticoids.23
It has been reported that increased soluble selec-
tins could be a promising serological marker of the
severity of inflammation in bronchial asthmatic chil-
dren.24The present study suggests that elevated levels
of  these  molecules  may  reflect  the  inflammatory
process in  asthmatic adults.  Because  attachment of
circulating cells to endothelium is a key event in their
recruitment to the inflammatory sites, the association
of  higher  concentrations  of  soluble  selectins  with
severe asthma suggests that E-selectin and VCAM-1 are
involved in the inflammatory pathways of this kind of
asthma.
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